Healthcare -
Biotechnology - NASDAQ - US
$ 2.9
0.694 %
$ 71.6 M
Market Cap
-1.27
P/E
AADI - COST OF REVENUE
Cost of Revenue AADI - Aadi Bioscience, Inc.
2.81 M
LAST VALUE
219.02%
2 YEAR CAGR
0.00%
5 YEAR CAGR
61.81%
10 YEAR CAGR